Literature DB >> 3774706

Gait ataxia as a presenting symptom of malignant epidural spinal cord compression.

S J Karp, R T Ho.   

Abstract

A 68 year old man with prostatic carcinoma developed spinal cord compression. The sole presenting feature was painless gait ataxia indistinguishable from cerebellar ataxia. He was investigated for cerebellar disease but the correct diagnosis was made when he subsequently presented with paraplegia and classical signs of spinal cord compression. Surgical decompression failed to produce neurological recovery. We discuss the importance of recognizing this unusual presentation of spinal cord compression, its possible mechanism and evidence that it may be under-reported.

Entities:  

Mesh:

Year:  1986        PMID: 3774706      PMCID: PMC2418824          DOI: 10.1136/pgmj.62.730.745

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Epidural spinal cord compression from metastatic tumor: diagnosis and treatment.

Authors:  R W Gilbert; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

2.  Prognostic factors in the management of metastatic epidural spinal cord compression.

Authors:  S G Tang; J E Byfield; T R Sharp; J F Utley; L Quinol; S L Seagren
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  Spinal metastases. A retrospective survey from a general hospital.

Authors:  R J Stark; R A Henson; S J Evans
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

4.  Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol.

Authors:  H S Greenberg; J H Kim; J B Posner
Journal:  Ann Neurol       Date:  1980-10       Impact factor: 10.422

  4 in total
  1 in total

1.  Upper limbs dysmetria caused by cervical spinal cord injury: a case report.

Authors:  Hsun-Chang Lin; Chun-Hung Chen; Gim-Thean Khor; Poyin Huang
Journal:  BMC Neurol       Date:  2009-09-24       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.